Autophagy: a promising therapeutic target for improving mesenchymal stem cell biological functions

Mol Cell Biochem. 2021 Feb;476(2):1135-1149. doi: 10.1007/s11010-020-03978-2. Epub 2020 Nov 16.

Abstract

Mesenchymal stem cells (MSCs) are considered to be a promising therapeutic material due to their capacities for self-renewal, multilineage differentiation, and immunomodulation and have attracted great attention in regenerative medicine. However, MSCs may lose their biological functions because of donor age or disease and environmental pressure before and after transplantation, which hinders the application of MSC-based therapy. As a major intracellular lysosome-dependent degradative process, autophagy plays a pivotal role in maintaining cellular homeostasis and withstanding environmental pressure and may become a potential therapeutic target for improving MSC functions. Recent studies have demonstrated that the regulation of autophagy is a promising approach for improving the biological properties of MSCs. More in-depth investigations about the role of autophagy in MSC biology are required to contribute to the clinical application of MSCs. In this review, we focus on the role of autophagy regulation by various physical and chemical factors on the biological functions of MSCs in vitro and in vivo, and provide some strategies for enhancing the therapeutic efficacy of MSCs.

Keywords: Angiogenesis; Autophagy; Differentiation; Immunosuppression; MSCs; Survival.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy*
  • Cell Differentiation
  • Homeostasis*
  • Humans
  • Mesenchymal Stem Cell Transplantation / methods*
  • Mesenchymal Stem Cells / cytology*
  • Regenerative Medicine*